Experience of medical professionals with Azoximer bromide as prophylactic treatment for COVID-19 patients in Chuvashia Republic, Russia

Abstract

In March 2020, the Emergency Health Care Hospital in Chuvashia Republic, Russia, was converted into a specialised COVID-19 hospital. Azoximer bromide, a high molecular weight synthetic immune modulator drug was chosen by a frontline team of 52 medical professionals at the Emergency Health Care Hospital, who agreed to self-administer azoximer bromide as a prophylactic treatment against COVID-19. During the dosing period, all 52 professionals, with one exception, remained symptom free and tested negative for COVID-19. Like many European countries, Russia has been markedly affected by COVID‐19. The first step in ‘fighting’ the epidemic was a nationwide lockdown, implemented on March 30, 2020. Most of the multidisciplinary hospitals were rapidly repurposed as dedicated COVID 19 centres and health workers re-trained and deployed as infectious disease specialists. The outcome was the creation of a cohort of trained and dedicated staff readily available to support patients in intensive care units who needed mechanical ventilation.

Keywords

• covid-19
• azoximer bromide
• prophylactic
• pandemic
• epidemic.